125 related articles for article (PubMed ID: 392484)
21. The putative ABC transporter encoded by the orf19.4531 plays a role in the sensitivity of Candida albicans cells to azole antifungal drugs.
Jiang L; Xu D; Chen Z; Cao Y; Gao P; Jiang Y
FEMS Yeast Res; 2016 May; 16(3):. PubMed ID: 26975389
[TBL] [Abstract][Full Text] [Related]
22. Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis.
Jackson CJ; Lamb DC; Kelly DE; Kelly SL
FEMS Microbiol Lett; 2000 Nov; 192(2):159-62. PubMed ID: 11064188
[TBL] [Abstract][Full Text] [Related]
23. Enhanced production of farnesol by Candida albicans treated with four azoles.
Hornby JM; Nickerson KW
Antimicrob Agents Chemother; 2004 Jun; 48(6):2305-7. PubMed ID: 15155241
[TBL] [Abstract][Full Text] [Related]
24. Antifungal antibiotic sensitivity testing: use of Autobac 1 for standardization purposes.
Seguela JP; Lepargneur JP; Saveres C; Cazaux M; Riser A; Linas MD
Mycopathologia; 1980 Aug; 72(1):13-9. PubMed ID: 7421978
[TBL] [Abstract][Full Text] [Related]
25. New azoles with potent antifungal activity: design, synthesis and molecular docking.
Che X; Sheng C; Wang W; Cao Y; Xu Y; Ji H; Dong G; Miao Z; Yao J; Zhang W
Eur J Med Chem; 2009 Oct; 44(10):4218-26. PubMed ID: 19539408
[TBL] [Abstract][Full Text] [Related]
26. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro.
Ramage G; Jose A; Coco B; Rajendran R; Rautemaa R; Murray C; Lappin DF; Bagg J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):456-60. PubMed ID: 21310633
[TBL] [Abstract][Full Text] [Related]
27. Antifungal activity of alpha-mangostin against Candida albicans.
Kaomongkolgit R; Jamdee K; Chaisomboon N
J Oral Sci; 2009 Sep; 51(3):401-6. PubMed ID: 19776506
[TBL] [Abstract][Full Text] [Related]
28. Mode of action of clotrimazole: implications for therapy.
Haller I
Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 2):939-44. PubMed ID: 3895959
[TBL] [Abstract][Full Text] [Related]
29. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.
Hitchcock CA; Russell NJ; Barrett-Bee KJ
Crit Rev Microbiol; 1987; 15(1):111-5. PubMed ID: 3319418
[TBL] [Abstract][Full Text] [Related]
30. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
[TBL] [Abstract][Full Text] [Related]
31. Trafficking through the late endosome significantly impacts Candida albicans tolerance of the azole antifungals.
Luna-Tapia A; Kerns ME; Eberle KE; Jursic BS; Palmer GE
Antimicrob Agents Chemother; 2015 Apr; 59(4):2410-20. PubMed ID: 25666149
[TBL] [Abstract][Full Text] [Related]
32. Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.
Lees ND; Broughton MC; Sanglard D; Bard M
Antimicrob Agents Chemother; 1990 May; 34(5):831-6. PubMed ID: 2193620
[TBL] [Abstract][Full Text] [Related]
33. [Fungi isolated from the vagina and their susceptibility to antifungals].
Macura AB; Skóra M
Ginekol Pol; 2012 Jun; 83(6):433-8. PubMed ID: 22880463
[TBL] [Abstract][Full Text] [Related]
34. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
Lynch ME; Sobel JD
J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
[TBL] [Abstract][Full Text] [Related]
35. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
36. In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect.
Gunderson SM; Hoffman H; Ernst EJ; Pfaller MA; Klepser ME
Antimicrob Agents Chemother; 2000 Oct; 44(10):2887-90. PubMed ID: 10991881
[TBL] [Abstract][Full Text] [Related]
37. Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis.
Sharma M; Manoharlal R; Negi AS; Prasad R
FEMS Yeast Res; 2010 Aug; 10(5):570-8. PubMed ID: 20528949
[TBL] [Abstract][Full Text] [Related]
38. [The sensitivity of yeasts from the Candida genus isolated from cancer patients to polyene antifungals].
Alves SH; Cury AE
Rev Inst Med Trop Sao Paulo; 1992; 34(3):251-4. PubMed ID: 1342079
[TBL] [Abstract][Full Text] [Related]
39. Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial Drugs.
Eldesouky HE; Mayhoub A; Hazbun TR; Seleem MN
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263071
[TBL] [Abstract][Full Text] [Related]
40. Azole susceptibility and resistance in Candida dubliniensis.
Pinjon E; Moran GP; Coleman DC; Sullivan DJ
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1210-4. PubMed ID: 16246083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
